Medical Press Release - Medika Life : Keeping you informed

A report on the Dental Surgical Market 2020-2024 by Technavia. The dental surgical equipment market is expected to grow by USD 1.42 billion during 2020-2024, expanding at a CAGR of almost 6%

Unique Global Symposium Suggests Vital Shifts in Cancer Treatment

Medika Life - September 27, 2020

More than 30 preeminent experts to present virtually; vast degree of structural disease change, high speed of cancer evolution, rarely considered until now

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

A New A.I. Based Solution to Nurse Burn-out and Turnover

Medika Life - September 16, 2020

What can we do to ensure that those we rely upon to care for us, are being supported in this essential, important work?

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

The 50 Most Influential Leaders in Pharmacy 2022 Awards

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

Children with no COVID-19 symptoms may shed virus for weeks

South University Announces New MSPA Program at West Palm Beach Campus

EDITORS CHOICE

Dental Surgical Equipment Market 2020-2024

Unique Global Symposium Suggests Vital Shifts in Cancer Treatment

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

A New A.I. Based Solution to Nurse Burn-out and Turnover

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories